Optimal Attained LDL-Cholesterol Levels in Patients Who Achieved ≥50% LDL Reduction After PCI

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

135877 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-01

Study Completion Date

2025-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

For the management of low-density lipoprotein-cholesterol (LDL-C), some guidelines recommend initial statin treatment with high-intensity statins to achieve at least a 50% reduction in LDL-C levels. High-intensity or maximally tolerated intensity can be maintained without a target goal. However, the European guideline recommends less than 55 mg/dL of LDL-C after PCI.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Optimal LDL-C Target in High-risk Patients After PCI

NCT06821711

Chronic Coronary Syndrome Acute Coronary Syndromes Percutaneous Coronary Intervention +1 more

NOT_YET_RECRUITING NA

Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease

NCT02579499

Coronary Artery Diseasse

UNKNOWN PHASE4

Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in PCI Patients

NCT02561845

PCI Patients

WITHDRAWN

Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease: I-OLD Trial

NCT05361421

Cardiovascular Disease

RECRUITING PHASE4

Low- and Moderate-intensity Statin and Clinical Outcome of Primary Prevention in Individuals Aged >70 Years: the SCOPE-70 RCT Study

NCT03770312

Healthy Elderly Individuals With High LDL-cholesterol or Risk of Cardiovascular Disease

RECRUITING PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To investigate the Optimal Attained LDL-C Levels in Patients Who Achieved ≥50% LDL-C Reduction After PCI.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease Hyperlipidemias

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

>=50% LDL-C reduction

LDL-C reduction \>=50%

Further divided by LDL \<55mg/dL 55\< LDL \< 70 mg/dL LDL \> 70 mg/dL

LDL reduction therapy

Intervention Type DRUG

LDL reduction therapy

<50% LDL-C reduction

LDL-C reduction \<50%

LDL reduction therapy

Intervention Type DRUG

LDL reduction therapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LDL reduction therapy

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients receiving PCI with health check up before and after PCI within 3 years

Exclusion Criteria

* Patients receiving statin before PCI
* Patients with liver cirrhosis
* Patients with cancer
* Patients without prescription of statin
* Patients with LDL-C \<55 mg/dL before PCI

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No